Vericel prices $75M follow-on

Cell therapy developer Vericel Corp. (NASDAQ:VCEL) raised $74.8 million through the sale of 5 million

Read the full 155 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE